Brief: Biocartis Announces Partnership With Endpoint Health
03/11/2020 06:04
Nov 3 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* BIOCARTIS ANNOUNCES PARTNERSHIP WITH ENDPOINT HEALTH TO
DEVELOP
NOVEL COMPANION DIAGNOSTIC IN CRITICAL ILLNESS
* PARTNERSHIP TARGETS DEVELOPMENT AND COMMERCIALIZATION OF A
NOVEL
COMPANION DIAGNOSTIC (CDX) TEST(1) ON IDYLLA™, BIOCARTIS' RAPID
AND EASY-TO-USE MOLECULAR DIAGNOSTICS PLATFORM
Source text for Eikon: ID:nGNE6Zqb2f
Further company coverage: BCART.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies